Beginning Cash: The amount of cash reported by the company on its previous statement.
Evogene Ltd. (EVGN) had Beginning Cash of $15.30M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.85M |
|
$-8.48M |
|
$4.09M |
|
$-0.24M |
|
$17.89M |
|
$-14.03M |
|
$0.54M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-7.83M |
|
$-13.50M |
|
$-14.03M |
|
$-11.57M |
|
7.87M |
|
7.87M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$15.63M |
|
$0.81M |
|
$4.42M |
|
$20.05M |
|
$3.44M |
|
-- |
|
$4.63M |
|
$8.07M |
|
$11.97M |
|
$11.97M |
|
$11.97M |
|
8.72M |
|
| Cash Flow Statement Financials | |
$-13.50M |
|
$17.74M |
|
$-6.60M |
|
|
Beginning Cash |
$15.30M |
$12.96M |
|
$-2.35M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|